Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
COMPASS Pathways plc
CMPS | US
5.34
USD-0.07
-1.29%
CMPS | US
About COMPASS Pathways plc
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
30/06/2024
As of date
23/03/2026
Close
5.34
Open
5.52
High
5.55
Low
5.25
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360 a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London the United Kingdom.
View LessCMPS | US
Risk
60.1
Sharpe
0.80
Luna's Score
43/100
Recommendation
Sell
Luna says (CMPS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
71.3%1 month
60.1%3 months
94.4%6 months
85.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.93
Debt to equity
0.14
Debt to assets
0.12
Ent. to EBITDA
-3.51
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-141.30M
MarketCap
365.19M
MarketCap(USD)
365.19M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-70.90
Short ratio
14.71
Short perc.
11.16
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.30
Range1M
2.85
Range3M
3.65
Volumes: Market Activity
Rel. volume
1.36
Price X volume
21.48M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.51 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 22.94 | - |
| Price to Book | 1.93 | 14.91 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 94.42 | - | Riskier |
| Debt to Equity | 0.14 | 5.15 | Cheaper |
| Debt to Assets | 0.12 | 0.46 | Cheaper |
| Market Cap | 365.19M | - | Emerging |
